WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009063247) NOVEL CRYSTALLINE FORMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/063247    International Application No.:    PCT/GB2008/051067
Publication Date: 22.05.2009 International Filing Date: 14.11.2008
IPC:
C07D 209/14 (2006.01), A61K 31/404 (2006.01), A61P 1/04 (2006.01), A61P 1/08 (2006.01)
Applicants: GENERICS [UK] LIMITED [GB/GB]; Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG (GB) (For All Designated States Except US).
GAITONDE, Abhay [IN/IN]; (IN) (For US Only).
MANOJKUMAR, Bindu [IN/IN]; (IN) (For US Only).
SONAWANE, Sandeep [IN/IN]; (IN) (For US Only).
KOKANE, Dattatrey [IN/IN]; (IN) (For US Only).
PADALKAR, Vikas [IN/IN]; (IN) (For US Only)
Inventors: GAITONDE, Abhay; (IN).
MANOJKUMAR, Bindu; (IN).
SONAWANE, Sandeep; (IN).
KOKANE, Dattatrey; (IN).
PADALKAR, Vikas; (IN)
Agent: ELEND, Almut; Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge Cambridgeshire CB4 0WZ (GB)
Priority Data:
2258/MUM/2007 15.11.2007 IN
Title (EN) NOVEL CRYSTALLINE FORMS
(FR) NOUVELLES FORMES CRISTALLINES
Abstract: front page image
(EN)The present invention relates to novel crystalline forms of the salicylate salt of tegaserod, and to processes for the preparation of these novel forms. The invention also relates to pharmaceutical compositions containing these novel polymorphs,and to uses of said compositions to provide methods of treating patients suffering from gastrointestinal disorders.
(FR)L'invention concerne de nouvelles formes cristallines d'un sel salicylate de tégasérod et des procédés de préparation de ces nouvelles formes. L'invention concerne également des compositions pharmaceutiques contenant ces nouveaux polymorphes, et les utilisations de ces compositions dans des traitements pour des patients souffrant de troubles gastro-intestinaux.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)